In the SWI/SNF complex, BRG1 (SMARCA4) and BRM (SMARCA2) act as ATPases that reorganize chromatin and support DNA repair; their loss disrupts normal gene expression, increasing AML cell resistance to chemotherapy (Chambers et al., 2023; Yang et al., 2025). This evidence concerns the gene SMARCA2 and acute myeloid leukemia.